{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:17:29Z","timestamp":1773929849650,"version":"3.50.1"},"reference-count":327,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.pharmthera.2021.108011","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T12:30:35Z","timestamp":1633350635000},"page":"108011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Biologically active lipids in the regulation of lymphangiogenesis in disease states"],"prefix":"10.1016","volume":"232","author":[{"given":"Masataka","family":"Majima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2021.108011_bb0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1388-1981(99)00164-X","article-title":"The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs","volume":"1483","author":"Abramovitz","year":"2000","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH757>3.0.CO;2-G","article-title":"Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis","volume":"193","author":"Achen","year":"2001","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1440-1827.2007.02077.x","article-title":"Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases","volume":"57","author":"Adachi","year":"2007","journal-title":"Pathology International"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrm2183","article-title":"Molecular regulation of angiogenesis and lymphangiogenesis","volume":"8","author":"Adams","year":"2007","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10456-013-9404-3","article-title":"The inflammatory response of lymphatic endothelium","volume":"17","author":"Aebischer","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0030","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature05936","article-title":"Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis","volume":"448","author":"Ago","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1387\/ijdb.103226ia","article-title":"Molecular mechanisms of lymphangiogenesis in development and cancer","volume":"55","author":"Albrecht","year":"2011","journal-title":"The International Journal of Developmental Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1338239","article-title":"EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity","volume":"6","author":"Albu","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0045","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nm.2545","article-title":"The lymphatic vasculature in disease","volume":"17","author":"Alitalo","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0050","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04480","article-title":"Lymphangiogenesis in development and human disease","volume":"438","author":"Alitalo","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1254\/jjp.87.181","article-title":"Adenylate cyclase\/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in vivo","volume":"87","author":"Amano","year":"2001","journal-title":"Japanese Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20021408","article-title":"Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth","volume":"197","author":"Amano","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-0774.2002.tb00095.x","article-title":"Cyclooxygenase-2 and adenylate cyclase\/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in rat sponge implants","volume":"15","author":"Amano","year":"2002","journal-title":"Human Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/cvr\/cvv139","article-title":"Thromboxane A2 induces blood flow recovery via platelet adhesion to ischaemic regions","volume":"107","author":"Amano","year":"2015","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jss.2016.04.011","article-title":"Thromboxane A synthase enhances blood flow recovery from hindlimb ischemia","volume":"204","author":"Amano","year":"2016","journal-title":"The Journal of Surgical Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0080","doi-asserted-by":"crossref","first-page":"48737","DOI":"10.1074\/jbc.M206812200","article-title":"Serum lysophosphatidic acid is produced through diverse phospholipase pathways","volume":"277","author":"Aoki","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tips.2012.02.004","article-title":"Prostaglandins and chronic inflammation","volume":"33","author":"Aoki","year":"2012","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/lrb.2012.0010","article-title":"The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis","volume":"10","author":"Aoyagi","year":"2012","journal-title":"Lymphatic Research and Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCRESAHA.115.306544","article-title":"Lymphatic system in cardiovascular medicine","volume":"118","author":"Aspelund","year":"2016","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrm2639","article-title":"Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system","volume":"10","author":"Augustin","year":"2009","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0105","first-page":"843","article-title":"Endometriosis: Pathogenesis, diagnosis, therapy and association with cancer (review)","volume":"19","author":"Baldi","year":"2008","journal-title":"Oncology Reports"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0110","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1084\/jem.20062596","article-title":"Functionally specialized junctions between endothelial cells of lymphatic vessels","volume":"204","author":"Baluk","year":"2007","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0115","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00018-012-1110-6","article-title":"Flow control in our vessels: Vascular valves make sure there is no way back","volume":"70","author":"Bazigou","year":"2013","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mvr.2014.07.008","article-title":"Primary and secondary lymphatic valve development: Molecular, functional and mechanical insights","volume":"96","author":"Bazigou","year":"2014","journal-title":"Microvascular Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0125","first-page":"1315","article-title":"Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer","volume":"62","author":"Beasley","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200407123","article-title":"A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells","volume":"169","author":"Bektas","year":"2005","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0135","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1242\/dev.078550","article-title":"S1P1 inhibits sprouting angiogenesis during vascular development","volume":"139","author":"Ben Shoham","year":"2012","journal-title":"Development"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0140","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1021\/cb5001907","article-title":"Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness","volume":"9","author":"Benjamin","year":"2014","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/pmic.200900195","article-title":"Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture","volume":"10","author":"Bernhart","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0150","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2010-02-270876","article-title":"Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling","volume":"116","author":"Bertozzi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/imr.12413","article-title":"The lymphatic vasculature: Development and role in shaping immunity","volume":"271","author":"Betterman","year":"2016","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biopha.2018.12.021","article-title":"Vascular endothelial growth factor receptor 1 tyrosine kinase signaling facilitates healing of DSS-induced colitis by accumulation of Tregs in ulcer area","volume":"111","author":"Betto","year":"2019","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0165","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1021\/cr200273u","article-title":"Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors","volume":"111","author":"Blaho","year":"2011","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0170","doi-asserted-by":"crossref","first-page":"H1897","DOI":"10.1152\/ajpheart.00260.2011","article-title":"Nitric oxide formation by lymphatic bulb and valves is a major regulatory component of lymphatic pumping","volume":"301","author":"Bohlen","year":"2011","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0175","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/37635","article-title":"Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2","volume":"390","author":"Bonventre","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0180","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.111.250738","article-title":"CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo","volume":"109","author":"Bos","year":"2011","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0185","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2005-03-0979","article-title":"A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation","volume":"106","author":"Braun","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10557-008-6132-9","article-title":"Phospholipase A2 biochemistry","volume":"23","author":"Burke","year":"2009","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0195","first-page":"273","article-title":"Tumor cell-mediated neovascularization and lymphangiogenesis contrive tumor progression and cancer metastasis","volume":"1836","author":"Cao","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0200","first-page":"875","article-title":"Women\u2019s experiences of lymphedema","volume":"24","author":"Carter","year":"1997","journal-title":"Oncology Nursing Forum"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0205","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ydbio.2004.01.001","article-title":"Regulation of limb development by the sphingosine 1-phosphate receptor S1p1\/EDG-1 occurs via the hypoxia\/VEGF axis","volume":"268","author":"Chae","year":"2004","journal-title":"Developmental Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.critrevonc.2016.11.003","article-title":"Hyperglycemia, tumorigenesis, and chronic inflammation","volume":"108","author":"Chang","year":"2016","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0215","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nm1078","article-title":"Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity","volume":"10","author":"Chen","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0220","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/15384047.2016.1156273","article-title":"Metformin inhibits prostate cancer cell proliferation, migration, and tumor growth through upregulation of PEDF expression","volume":"17","author":"Chen","year":"2016","journal-title":"Cancer Biology & Therapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0225","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1172\/JCI87442","article-title":"Laminar flow downregulates Notch activity to promote lymphatic sprouting","volume":"127","author":"Choi","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0230","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.111.030296","article-title":"9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: Therapeutic implications of 9-cis retinoic acid for secondary lymphedema","volume":"125","author":"Choi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","article-title":"LPA receptors: Subtypes and biological actions","volume":"50","author":"Choi","year":"2010","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/pr.54.2.265","article-title":"International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature","volume":"54","author":"Chun","year":"2002","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0245","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/pr.110.003111","article-title":"International union of basic and clinical pharmacology. LXXVIII. Lysophospholipid receptor nomenclature","volume":"62","author":"Chun","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0260","doi-asserted-by":"crossref","first-page":"571100","DOI":"10.3389\/fonc.2020.571100","article-title":"Hematogenous dissemination of breast cancer cells from lymph nodes is mediated by tumor microenvironment of metastasis doorways","volume":"10","author":"Coste","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0265","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.ico.0000183485.85636.ff","article-title":"Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation","volume":"25","author":"Cursiefen","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0270","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-immunol-020711-075011","article-title":"Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs","volume":"30","author":"Cyster","year":"2012","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0275","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0002-9440(10)64328-3","article-title":"Tumor lymphangiogenesis: A novel prognostic indicator for cutaneous melanoma metastasis and survival","volume":"162","author":"Dadras","year":"2003","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0280","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/ajt.13564","article-title":"Ischemia-reperfusion injury enhances lymphatic endothelial VEGFR3 and rejection in cardiac allografts","volume":"16","author":"Dashkevich","year":"2016","journal-title":"American Journal of Transplantation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097771","article-title":"Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers","volume":"9","author":"David","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.devcel.2009.01.004","article-title":"The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications","volume":"16","author":"Dejana","year":"2009","journal-title":"Developmental Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2015.12.011","article-title":"Tumor lymphangiogenesis and new drug development","volume":"99","author":"Dieterich","year":"2016","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0300","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10456-013-9406-1","article-title":"Lymphatic vessels: New targets for the treatment of inflammatory diseases","volume":"17","author":"Dieterich","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0305","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.0903180","article-title":"Cutting edge: Lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation","volume":"184","author":"Dietrich","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0310","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12307-008-0014-3","article-title":"Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence","volume":"1","author":"Doekhie","year":"2008","journal-title":"Cancer Microenvironment"},{"issue":"Pt 3","key":"10.1016\/j.pharmthera.2021.108011_bb0315","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1042\/bj2910677","article-title":"The bioactive phospholipid lysophosphatidic acid is released from activated platelets","volume":"291","author":"Eichholtz","year":"1993","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0320","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/sj.onc.1201090","article-title":"Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia","volume":"14","author":"Enholm","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0325","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jnci\/93.2.96","article-title":"Arm edema in breast cancer patients","volume":"93","author":"Erickson","year":"2001","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0330","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.cmet.2017.07.020","article-title":"The lymphatic vasculature: Its role in adipose metabolism and obesity","volume":"26","author":"Escobedo","year":"2017","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4712","article-title":"Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma","volume":"9","author":"Fankhauser","year":"2017","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0340","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nature07391","article-title":"Sox18 induces development of the lymphatic vasculature in mice","volume":"456","author":"Fran\u00e7ois","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0345","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1074\/jbc.M109440200","article-title":"Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2","volume":"277","author":"Fujino","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0350","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1172\/JCI60746","article-title":"The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice","volume":"122","author":"Fukuhara","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0355","first-page":"2771","article-title":"The role of type D prostanoid receptors and PPAR\u03b3 in gastric cancer progression","volume":"34","author":"Fukuoka","year":"2014","journal-title":"Anticancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0360","doi-asserted-by":"crossref","first-page":"9794","DOI":"10.1158\/0008-5472.CAN-06-2067","article-title":"Targeting prostaglandin E EP receptors to inhibit metastasis","volume":"66","author":"Fulton","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0365","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1074\/jbc.M110.162867","article-title":"Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation","volume":"286","author":"Fumagalli","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0370","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.devcel.2012.08.005","article-title":"The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2","volume":"23","author":"Gaengel","year":"2012","journal-title":"Developmental Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0375","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","article-title":"Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1","volume":"3","author":"Gale","year":"2002","journal-title":"Developmental Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0380","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0385","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/CIRCRESAHA.109.206326","article-title":"Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity","volume":"106","author":"Galvagni","year":"2010","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0390","first-page":"163","article-title":"Anatomic, physiologic, bacteriologic and immunologic aspects of peritonitis","volume":"97","author":"Gandawidjaja","year":"1997","journal-title":"Acta Chirurgica Belgica"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0395","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0005-2760(89)90112-4","article-title":"Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin","volume":"1001","author":"Gerrard","year":"1989","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0400","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/pros.20994","article-title":"Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells","volume":"69","author":"Gibbs","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0405","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice. Endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0410","doi-asserted-by":"crossref","first-page":"H2176","DOI":"10.1152\/ajpheart.01011.2006","article-title":"Regulation of lymphatic capillary regeneration by interstitial flow in skin","volume":"292","author":"Goldman","year":"2007","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0415","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: Key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Greenhough","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0420","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1210\/en.2005-1635","article-title":"Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0425","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/art.24764","article-title":"Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis","volume":"60","author":"Guo","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0430","doi-asserted-by":"crossref","first-page":"583786","DOI":"10.1155\/2013\/583786","article-title":"Diabetes and risk of cancer","volume":"2013","author":"Habib","year":"2013","journal-title":"ISRN Oncology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0435","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/lrb.2016.0015","article-title":"Animal models of secondary lymphedema: New approaches in the search for therapeutic options","volume":"15","author":"Hadrian","year":"2017","journal-title":"Lymphatic Research and Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0440","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0016-5085(98)70646-8","article-title":"The pathobiology of peritonitis","volume":"114","author":"Hall","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031794","article-title":"New model of macrophage acquisition of the lymphatic endothelial phenotype","volume":"7","author":"Hall","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0450","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jphs.2020.05.003","article-title":"Lymphangiogenesis induced by vascular endothelial growth factor receptor 1 signaling contributes to the progression of endometriosis in mice","volume":"143","author":"Hattori","year":"2020","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0455","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jnci\/94.11.819","article-title":"Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling","volume":"94","author":"He","year":"2002","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0460","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1158\/0008-5472.CAN-04-4576","article-title":"Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels","volume":"65","author":"He","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0465","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","article-title":"Characterization of the human cysteinyl leukotriene 2 receptor","volume":"275","author":"Heise","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0470","doi-asserted-by":"crossref","first-page":"15779","DOI":"10.1073\/pnas.0503681102","article-title":"Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism","volume":"102","author":"Helm","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0475","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.2047-2927.2012.00015.x","article-title":"Lymphangiogenesis in chronic inflammation in the testis","volume":"1","author":"Hirai","year":"2013","journal-title":"Andrology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0480","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1349-7006.2009.01142.x","article-title":"From tumor lymphangiogenesis to lymphvascular niche","volume":"100","author":"Hirakawa","year":"2009","journal-title":"Cancer Science"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0485","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/349617a0","article-title":"Cloning and expression of cDNA for a human thromboxane A2 receptor","volume":"349","author":"Hirata","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0490","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/ncb1794","article-title":"The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase","volume":"10","author":"Hiratsuka","year":"2008","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0495","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bbalip.2008.07.003","article-title":"The vascular S1P gradient-cellular sources and biological significance","volume":"1781","author":"Hla","year":"2008","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0500","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1600-0897.1997.tb00319.x","article-title":"Peritoneal cellular immunity and endometriosis","volume":"38","author":"Ho","year":"1997","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0505","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ng.321","article-title":"Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting","volume":"41","author":"Hogan","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0510","doi-asserted-by":"crossref","first-page":"11984","DOI":"10.1111\/jcmm.15823","article-title":"Inhibition of receptor activity-modifying protein 1 suppresses the development of endometriosis and the formation of blood and lymphatic vessels","volume":"24","author":"Honda","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162532","article-title":"Signaling of prostaglandin E receptors, EP3 and EP4 facilitates wound healing and lymphangiogenesis with enhanced recruitment of M2 macrophages in mice","volume":"11","author":"Hosono","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0520","doi-asserted-by":"crossref","first-page":"110264","DOI":"10.1016\/j.biopha.2020.110264","article-title":"Prostaglandin E receptor EP4 stimulates lymphangiogenesis to promote mucosal healing during DSS-induced colitis","volume":"128","author":"Hosono","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0525","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/ATVBAHA.110.222356","article-title":"Roles of prostaglandin E2-EP3\/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation","volume":"31","author":"Hosono","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0530","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1159\/000494177","article-title":"High glucose induces VEGF-C expression via the LPA1\/3-Akt-ROS-LEDGF signaling axis in human prostate cancer PC-3 Cells","volume":"50","author":"Huang","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0535","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1182\/blood-2010-10-316356","article-title":"An important role of lymphatic vessel activation in limiting acute inflammation","volume":"117","author":"Huggenberger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0540","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1084\/jem.20100559","article-title":"Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation","volume":"207","author":"Huggenberger","year":"2010","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0545","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.108.172676","article-title":"Angiopoietin-2 exocytosis is stimulated by sphingosine-1-phosphate in human blood and lymphatic endothelial cells","volume":"29","author":"Jang","year":"2009","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0550","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/CIRCULATIONAHA.113.002779","article-title":"CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation","volume":"129","author":"Jeltsch","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0555","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1038\/s41598-017-04982-1","article-title":"Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1","volume":"7","author":"Jha","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003812","article-title":"Hematopoietic stem cells contribute to lymphatic endothelium","volume":"3","author":"Jiang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0565","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1074\/jbc.273.12.6599","article-title":"A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities","volume":"273","author":"Joukov","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0570","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.devcel.2012.07.015","article-title":"Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development","volume":"23","author":"Jung","year":"2012","journal-title":"Developmental Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0575","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ni943","article-title":"Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity","volume":"4","author":"Kabashima","year":"2003","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0580","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/jid.2008.351","article-title":"Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis","volume":"129","author":"Kajiya","year":"2009","journal-title":"The Journal of Investigative Dermatology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0585","doi-asserted-by":"crossref","first-page":"L328","DOI":"10.1152\/ajplung.90431.2008","article-title":"Role of acylglycerol kinase in LPA-induced IL-8 secretion and transactivation of epidermal growth factor-receptor in human bronchial epithelial cells","volume":"296","author":"Kalari","year":"2009","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0590","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1254\/jjp.90.59","article-title":"Suppression of dextran sulfate sodium-induced colitis in kininogen-deficient rats and non-peptide B2 receptor antagonist-treated rats","volume":"90","author":"Kamata","year":"2002","journal-title":"Japanese Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0595","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2353\/ajpath.2006.051358","article-title":"Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis","volume":"169","author":"Kamoshita","year":"2006","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0600","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.173.3.1503","article-title":"Cysteinyl leukotrienes and their receptors: Cellular distribution and function in immune and inflammatory responses","volume":"173","author":"Kanaoka","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0605","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1074\/jbc.C113.453704","article-title":"Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand","volume":"288","author":"Kanaoka","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0610","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10350-006-0745-5","article-title":"Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer","volume":"50","author":"Kaneko","year":"2007","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0615","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1159\/000373928","article-title":"High glucose promotes tumor invasion and increases metastasis-associated protein expression in human lung epithelial cells by upregulating heme oxygenase-1 via reactive oxygen species or the TGF-\u03b21\/PI3K\/Akt signaling pathway","volume":"35","author":"Kang","year":"2015","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0620","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","article-title":"VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche","volume":"438","author":"Kaplan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0625","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/ni1013","article-title":"Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins","volume":"5","author":"Karkkainen","year":"2004","journal-title":"Nature Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0630","doi-asserted-by":"crossref","first-page":"12677","DOI":"10.1073\/pnas.221449198","article-title":"A model for gene therapy of human hereditary lymphedema","volume":"98","author":"Karkkainen","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0635","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccr.2011.12.026","article-title":"VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium","volume":"21","author":"Karnezis","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0640","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1084\/jem.194.6.F37","article-title":"Lymphatic vessels as targets of tumor therapy?","volume":"194","author":"Karpanen","year":"2001","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0645","first-page":"1786","article-title":"Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth","volume":"61","author":"Karpanen","year":"2001","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0650","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/labinvest.2011.84","article-title":"Role of COX-2 in lymphangiogenesis and restoration of lymphatic flow in secondary lymphedema","volume":"91","author":"Kashiwagi","year":"2011","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0655","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1182\/blood-2008-09-176776","article-title":"Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution","volume":"113","author":"Kataru","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0660","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.immuni.2010.12.016","article-title":"T lymphocytes negatively regulate lymph node lymphatic vessel formation","volume":"34","author":"Kataru","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0665","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2353\/ajpath.2010.090607","article-title":"COX-2 and prostaglandin EP3\/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems","volume":"176","author":"Katoh","year":"2010","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0670","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s000110050605","article-title":"Cyclooxygenase-2: Its rich diversity of roles and possible application of its selective inhibitors","volume":"49","author":"Katori","year":"2000","journal-title":"Inflammation Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0675","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1167449","article-title":"The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors","volume":"323","author":"Kawahara","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0680","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/jgh.13505","article-title":"RAMP1 suppresses mucosal injury from dextran sodium sulfate-induced colitis in mice","volume":"32","author":"Kawashima-Takeda","year":"2017","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0685","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1172\/JCI78888","article-title":"GATA2 is required for lymphatic vessel valve development and maintenance","volume":"125","author":"Kazenwadel","year":"2015","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0690","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/dvdy.24313","article-title":"Morphogenesis of the lymphatic vasculature: A focus on new progenitors and cellular mechanisms important for constructing lymphatic vessels","volume":"245","author":"Kazenwadel","year":"2016","journal-title":"Developmental Dynamics"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0695","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.ajpath.2013.02.025","article-title":"Lymphatic vessel memory stimulated by recurrent inflammation","volume":"182","author":"Kelley","year":"2013","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0700","first-page":"403","article-title":"Lymphatic neoangiogenesis in renal transplants: A driving force of chronic rejection?","volume":"19","author":"Kerjaschki","year":"2006","journal-title":"Journal of Nephrology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0705","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/pros.23342","article-title":"The association of diabetes and obesity with prostate cancer progression: HCaP-NC","volume":"77","author":"Khan","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0710","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1111\/bph.12678","article-title":"Lysophospholipid receptor nomenclature review: IUPHAR review 8","volume":"171","author":"Kihara","year":"2014","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0715","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1172\/JCI71607","article-title":"Inflammation-associated lymphangiogenesis: A double-edged sword?","volume":"124","author":"Kim","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0720","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2353\/ajpath.2009.090133","article-title":"Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm","volume":"175","author":"Kim","year":"2009","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0725","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1158\/0008-5472.CAN-10-2591","article-title":"CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche","volume":"70","author":"Kim","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0730","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biomaterials.2015.11.019","article-title":"Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro","volume":"78","author":"Kim","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0735","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/intimm\/dxw021","article-title":"Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients","volume":"28","author":"Kirilovsky","year":"2016","journal-title":"International Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0740","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.bjp.0701367","article-title":"Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells","volume":"122","author":"Kiriyama","year":"1997","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0745","doi-asserted-by":"crossref","first-page":"29367","DOI":"10.1074\/jbc.M403937200","article-title":"The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis","volume":"279","author":"Kono","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0750","first-page":"713","article-title":"Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats","volume":"63","author":"Krishnan","year":"2003","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0755","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopha.2009.04.039","article-title":"Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis","volume":"64","author":"Kubo","year":"2010","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0760","series-title":"Robbins basic pathology","first-page":"81","author":"Kumar","year":"2018"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0765","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/35018092","article-title":"A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development","volume":"406","author":"Kupperman","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0770","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1096\/fj.13-238998","article-title":"Roles of receptor activity-modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice","volume":"28","author":"Kurashige","year":"2014","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0775","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10555-018-9734-0","article-title":"Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer","volume":"37","author":"Lala","year":"2018","journal-title":"Cancer Metastasis Reviews"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0780","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/0008-5472.CAN-05-2001","article-title":"Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization","volume":"66","author":"LaMontagne","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0785","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0092-8674(00)81661-X","article-title":"Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate","volume":"99","author":"Lee","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0790","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1096\/fj.08-106088","article-title":"LPA1 is essential for lymphatic vessel development in zebrafish","volume":"22","author":"Lee","year":"2008","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0795","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1113\/jphysiol.2004.066118","article-title":"Revision of the Starling principle: New views of tissue fluid balance","volume":"557","author":"Levick","year":"2004","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0800","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/cvr\/cvq062","article-title":"Microvascular fluid exchange and the revised Starling principle","volume":"87","author":"Levick","year":"2010","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0805","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbrc.2013.09.104","article-title":"Lysophosphatidic acid induces reactive oxygen species generation by activating protein kinase C in PC-3 human prostate cancer cells","volume":"440","author":"Lin","year":"2013","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0810","article-title":"Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0815","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1007\/s00018-008-8314-9","article-title":"Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells","volume":"65","author":"Lin","year":"2008","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0820","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.cellsig.2008.06.008","article-title":"Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1\/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms","volume":"20","author":"Lin","year":"2008","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0825","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1158\/0008-5472.CAN-05-0408","article-title":"Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor","volume":"65","author":"Lin","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0830","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.bbalip.2018.07.005","article-title":"LPA1\/3 signaling mediates tumor lymphangiogenesis through promoting CRT expression in prostate cancer","volume":"1863","author":"Lin","year":"2018","journal-title":"Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0835","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4236\/jct.2017.82007","article-title":"Statins and metformin use is associated with lower PSA levels in prostate cancer patients presenting for radiation therapy","volume":"8","author":"Liu","year":"2017","journal-title":"Journal of Cancer Therapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0840","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","article-title":"Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation","volume":"106","author":"Liu","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0845","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0090-6980(02)00028-X","article-title":"Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2","volume":"68-69","author":"Loftin","year":"2002","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0850","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/gyno.1999.5624","article-title":"Lymphedema and lymphocysts following lymphadenectomy may be prevented by omentoplasty: A pilot study","volume":"75","author":"Logmans","year":"1999","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0855","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","article-title":"VEGFs and receptors involved in angiogenesis versus lymphangiogenesis","volume":"21","author":"Lohela","year":"2009","journal-title":"Current Opinion in Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0860","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0865","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1172\/JCI73777","article-title":"Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer","volume":"124","author":"Lyons","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0870","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm.1960","article-title":"Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism","volume":"15","author":"Machnik","year":"2009","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0875","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tips.2003.08.005","article-title":"Prostanoid receptor signaling relevant to tumor growth and angiogenesis","volume":"24","author":"Majima","year":"2003","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0880","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bjp.0703327","article-title":"Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants","volume":"130","author":"Majima","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0885","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-5198(19)31321-6","article-title":"Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants","volume":"75","author":"Majima","year":"1997","journal-title":"Japanese Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0890","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041019","article-title":"EP4 as a therapeutic target for aggressive human breast cancer","volume":"19","author":"Majumder","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0895","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1101\/gad.330105","article-title":"PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature","volume":"19","author":"M\u00e4kinen","year":"2005","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0900","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","article-title":"Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis","volume":"20","author":"Mandriota","year":"2001","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0905","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature06009","article-title":"Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase","volume":"448","author":"Martinez Molina","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0910","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1172\/JCI23874","article-title":"Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages","volume":"115","author":"Maruyama","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2015.10.008","article-title":"Roles of mPGES-1, an inducible prostaglandin E synthase, in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model","volume":"142","author":"Matsuda","year":"2015","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0920","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/ATVBAHA.120.315507","article-title":"Roles of thromboxane receptor signaling in enhancement of lipopolysaccharide-induced lymphangiogenesis and lymphatic drainage function in diaphragm","volume":"41","author":"Matsuda","year":"2021","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0925","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1097\/01.ASN.0000076078.50889.43","article-title":"Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: Aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels","volume":"14","author":"Matsui","year":"2003","journal-title":"Journal of American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0930","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1349-7006.2012.02200.x","article-title":"Thromboxane A\u2082 receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells","volume":"103","author":"Matsui","year":"2012","journal-title":"Cancer Science"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0935","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s10350-006-0792-y","article-title":"Lymphatic microvessel density is an independent prognostic factor in colorectal cancer","volume":"50","author":"Matsumoto","year":"2007","journal-title":"Diseases of the Colon and Rectum"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0940","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0300-9084(78)80784-6","article-title":"Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase","volume":"60","author":"Mauco","year":"1978","journal-title":"Biochimie"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0945","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1074\/jbc.M112.427344","article-title":"Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning","volume":"288","author":"Mendelson","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0950","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lfs.2015.03.015","article-title":"Adhesion of platelets through thromboxane A\u2082 receptor signaling facilitates liver repair during acute chemical-induced hepatotoxicity","volume":"132","author":"Minamino","year":"2015","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0955","doi-asserted-by":"crossref","first-page":"H431","DOI":"10.1152\/ajpheart.00466.2010","article-title":"Calcitonin gene-related peptide facilitates revascularization during hindlimb ischemia in mice","volume":"300","author":"Mishima","year":"2011","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0960","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jss.2017.05.124","article-title":"RAMP1 signaling improves lymphedema and promotes lymphangiogenesis in mice","volume":"219","author":"Mishima","year":"2017","journal-title":"The Journal of Surgical Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0965","doi-asserted-by":"crossref","first-page":"11113","DOI":"10.1128\/MCB.25.24.11113-11121.2005","article-title":"Essential role for sphingosine kinases in neural and vascular development","volume":"25","author":"Mizugishi","year":"2005","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0970","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad6352","article-title":"The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis","volume":"8","author":"Mlecnik","year":"2016","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0975","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1084\/jem.20140137","article-title":"Thromboxane A2 acts as tonic immunoregulator by preferential disruption of low-avidity CD4+ T cell-dendritic cell interactions","volume":"211","author":"Moalli","year":"2014","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0980","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-122-5-199503010-00001","article-title":"Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report","volume":"122","author":"Moertel","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0985","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.biopha.2005.05.005","article-title":"Regulatory expression of lipoxin A4 receptor in physiologically estrus cycle and pathologically endometriosis","volume":"59","author":"Motohashi","year":"2005","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0990","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.ajpath.2012.03.003","article-title":"Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells","volume":"180","author":"Mu","year":"2012","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb0995","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.neo.2015.09.003","article-title":"Lysophosphatidic acid up-regulates hexokinase II and glycolysis to promote proliferation of ovarian cancer cells","volume":"17","author":"Mukherjee","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1000","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2217\/bmt.15.20","article-title":"S1P promotes breast cancer progression by angiogenesis and lymphangiogenesis","volume":"4","author":"Mukhopadhyay","year":"2015","journal-title":"Breast Cancer Management"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-62703-227-8_6","article-title":"In vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography","volume":"961","author":"Mumprecht","year":"2013","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1010","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1158\/0008-5472.CAN-10-0896","article-title":"In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography","volume":"70","author":"Mumprecht","year":"2010","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1015","first-page":"28","article-title":"Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis","volume":"62","author":"Mutoh","year":"2002","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1020","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1096\/fj.12-219618","article-title":"Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network","volume":"27","author":"Nagahashi","year":"2013","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1025","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1158\/0008-5472.CAN-11-2167","article-title":"Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis","volume":"72","author":"Nagahashi","year":"2012","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10456-020-09718-w","article-title":"Lymphangiogenesis and accumulation of reparative macrophages contribute to liver repair after hepatic ischemia-reperfusion injury","volume":"23","author":"Nakamoto","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2007.10.005","article-title":"Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation","volume":"388","author":"Nakamura","year":"2008","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008380","article-title":"Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice","volume":"4","author":"Nakamura","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1258\/000456307782268147","article-title":"Serum lysophospholipase D\/autotaxin may be a new nutritional assessment marker: Study on prostate cancer patients","volume":"44","author":"Nakamura","year":"2007","journal-title":"Annals of Clinical Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1050","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1021\/cr100392s","article-title":"Leukotriene receptors","volume":"111","author":"Nakamura","year":"2011","journal-title":"Chemical Reviews"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10549-004-5783-x","article-title":"Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer","volume":"91","author":"Nakamura","year":"2005","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvq052","article-title":"Autotaxin--an LPA producing enzyme with diverse functions","volume":"148","author":"Nakanaga","year":"2010","journal-title":"Journal of Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/365166a0","article-title":"Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity","volume":"365","author":"Namba","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1070","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: Structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.aai8515","article-title":"Origins of lymphatic and distant metastases in human colorectal cancer","volume":"357","author":"Naxerova","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1080","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2010-11-319129","article-title":"The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development","volume":"118","author":"Niessen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coph.2008.11.010","article-title":"Lysophosphatidic acid (LPA) and its receptors","volume":"9","author":"Noguchi","year":"2009","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1090","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.107.704098","article-title":"Biological basis of therapeutic lymphangiogenesis","volume":"123","author":"Norrm\u00e9n","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1095","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1124\/mol.58.6.1601","article-title":"Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: Discovery of a subtype selective agonist","volume":"58","author":"Nothacker","year":"2000","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1100","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1349-7006.2009.01234.x","article-title":"Expression of autotaxin and acylglycerol kinase in prostate cancer: Association with cancer development and progression","volume":"100","author":"Nouh","year":"2009","journal-title":"Cancer Science"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.biopha.2010.12.008","article-title":"The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model","volume":"65","author":"Numao","year":"2011","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1110","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCULATIONAHA.109.910703","article-title":"Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts","volume":"121","author":"Nyk\u00e4nen","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1115","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.biopha.2014.10.022","article-title":"Downregulation of the proangiogenic prostaglandin E receptor EP3 and reduced angiogenesis in a mouse model of diabetes mellitus","volume":"68","author":"Oba","year":"2014","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1120","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1172\/JCI73530","article-title":"Prostanoid induces premetastatic niche in regional lymph nodes","volume":"124","author":"Ogawa","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1125","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.bjp.0703627","article-title":"Characterization of prostanoid receptors mediating contraction of the gastric fundus and ileum: Studies using mice deficient in prostanoid receptors","volume":"131","author":"Okada","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.cellbio.21.012704.132338","article-title":"The lymphatic vasculature: Recent progress and paradigms","volume":"21","author":"Oliver","year":"2005","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cell.2020.06.039","article-title":"The lymphatic vasculature in the 21","volume":"182","author":"Oliver","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.toxlet.2020.10.007","article-title":"Platelets prevent the development of monocrotaline-induced liver injury in mice","volume":"335","author":"Otaka","year":"2020","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1145","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)65021-3","article-title":"Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing","volume":"156","author":"Paavonen","year":"2000","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1150","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Reviews"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1155","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1084\/jem.20091240","article-title":"Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor","volume":"206","author":"Paruchuri","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1160","first-page":"462","article-title":"Lymphangiogenesis and tumor metastasis: Myth or reality?","volume":"7","author":"Pepper","year":"2001","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1165","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1170","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9","article-title":"Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis","volume":"92","author":"Petrek","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1175","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/nm1094","article-title":"Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis","volume":"10","author":"Petrova","year":"2004","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20171868","article-title":"Organ-specific lymphatic vasculature: From development to pathophysiology","volume":"215","author":"Petrova","year":"2018","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1185","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax4063","article-title":"Biological functions of lymphatic vessels","volume":"369","author":"Petrova","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1190","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/eji.200838140","article-title":"Distinct molecular composition of blood and lymphatic vascular endothelial cell junctions establishes specific functional barriers within the peripheral lymph node","volume":"38","author":"Pfeiffer","year":"2008","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1195","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1084\/jem.20091739","article-title":"Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels","volume":"206","author":"Pflicke","year":"2009","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1084\/jem.20091619","article-title":"Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning","volume":"207","author":"Pham","year":"2010","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1205","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/emboj.2011.456","article-title":"Mechanoinduction of lymph vessel expansion","volume":"31","author":"Planas-Paz","year":"2012","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrm.2017.36","article-title":"Vascular heterogeneity and specialization in development and disease","volume":"18","author":"Potente","year":"2017","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lfs.2003.09.031","article-title":"EP2 and EP4 prostanoid receptor signaling","volume":"74","author":"Regan","year":"2003","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1220","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1182\/blood-2005-01-0226","article-title":"Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels","volume":"106","author":"Religa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1225","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1158\/1078-0432.CCR-05-1077","article-title":"Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer","volume":"11","author":"Renyi-Vamos","year":"2005","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1230","doi-asserted-by":"crossref","first-page":"40771","DOI":"10.1074\/jbc.M110.105940","article-title":"Arginine 104 is a key catalytic residue in leukotriene C4 synthase","volume":"285","author":"Rinaldo-Matthis","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1235","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1158\/0008-5472.CAN-05-1843","article-title":"Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2","volume":"66","author":"Roberts","year":"2006","journal-title":"Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1240","doi-asserted-by":"crossref","first-page":"H1402","DOI":"10.1152\/ajpheart.00038.2006","article-title":"Characterization of lymphangiogenesis in a model of adult skin regeneration","volume":"291","author":"Rutkowski","year":"2006","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1245","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/modpathol.3800651","article-title":"Lymphatic microvessel density as prognostic marker in colorectal cancer","volume":"19","author":"Saad","year":"2006","journal-title":"Modern Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1250","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.RES.0000122383.60368.24","article-title":"Point-counterpoint of sphingosine 1-phosphate metabolism","volume":"94","author":"Saba","year":"2004","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1255","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.devcel.2011.12.020","article-title":"Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation","volume":"22","author":"Sabine","year":"2012","journal-title":"Developmental Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1260","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1172\/JCI80454","article-title":"FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature","volume":"125","author":"Sabine","year":"2015","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-7091-1646-3_6","article-title":"Interplay of mechanotransduction, FOXC2, connexins, and calcineurin signaling in lymphatic valve formation","volume":"214","author":"Sabine","year":"2014","journal-title":"Advances in Anatomy, Embryology, and Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1270","doi-asserted-by":"crossref","first-page":"16392","DOI":"10.1074\/jbc.M110.150177","article-title":"The catalytic architecture of leukotriene C4 synthase with two arginine residues","volume":"286","author":"Saino","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0002-9440(10)65550-2","article-title":"Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors","volume":"153","author":"Salven","year":"1998","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1280","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/mol.56.3.657","article-title":"Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor","volume":"56","author":"Sarau","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1285","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0002-9440(10)64255-1","article-title":"Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis","volume":"161","author":"Schoppmann","year":"2002","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1290","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1083\/jcb.201012094","article-title":"Lymphatic vascular morphogenesis in development, physiology, and disease","volume":"193","author":"Schulte-Merker","year":"2011","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1295","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fimmu.2019.00308","article-title":"Inflammation and Lymphatic Function","volume":"10","author":"Schwager","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ccr.2007.04.017","article-title":"Genes that distinguish physiological and pathological angiogenesis","volume":"11","author":"Seaman","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1305","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1038\/s41598-019-43185-8","article-title":"VEGF receptor 1-expressing macrophages recruited from bone marrow enhances angiogenesis in endometrial tissues","volume":"9","author":"Sekiguchi","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.011008.145616","article-title":"Lipid mediators in health and disease: Enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation","volume":"49","author":"Shimizu","year":"2009","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1315","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/(SICI)1097-4652(199909)180:3<431::AID-JCP14>3.0.CO;2-O","article-title":"Regulation of prostate cancer cell division by glucose","volume":"180","author":"Singh","year":"1999","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1320","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","article-title":"Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis","volume":"7","author":"Skobe","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: Structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1330","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2217\/clp.10.11","article-title":"Thromboxane and the thromboxane receptor in cardiovascular disease","volume":"5","author":"Smyth","year":"2010","journal-title":"Clinical Lipidology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1335","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.4049\/jimmunol.168.9.4333","article-title":"Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation","volume":"168","author":"Sombroek","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1340","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/nm0901-1048","article-title":"Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice","volume":"7","author":"Sonoshita","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1345","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1074\/jbc.R600028200","article-title":"Functions of the multifaceted family of sphingosine kinases and some close relatives","volume":"282","author":"Spiegel","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1350","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1101\/gad.1859310","article-title":"The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells","volume":"24","author":"Srinivasan","year":"2010","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1355","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","article-title":"Genes expressed in human tumor endothelium","volume":"289","author":"St Croix","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1360","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics","volume":"7","author":"Stacker","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1365","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3677","article-title":"Lymphangiogenesis and lymphatic vessel remodelling in cancer","volume":"14","author":"Stacker","year":"2014","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1370","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1128\/MCB.23.5.1534-1545.2003","article-title":"Inhibitory and stimulatory regulation of Rac and cell motility by the G12\/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform","volume":"23","author":"Sugimoto","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1375","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1194\/jlr.M200242-JLR200","article-title":"Lysophosphatidic acid, a growth factor-like lipid, in the saliva","volume":"43","author":"Sugiura","year":"2002","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1380","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1182\/blood-2010-03-272443","article-title":"LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis","volume":"116","author":"Sumida","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1385","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI79386","article-title":"Lymph flow regulates collecting lymphatic vessel maturation in vivo","volume":"125","author":"Sweet","year":"2015","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1390","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1096\/fj.02-0401fje","article-title":"Therapeutic lymphangiogenesis with human recombinant VEGF-C","volume":"16","author":"Szuba","year":"2002","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030254","article-title":"Inflammatory manifestations of experimental lymphatic insufficiency","volume":"3","author":"Tabibiazar","year":"2006","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1400","first-page":"80","article-title":"Twofer anti-vascular therapy targeting sphingosine-1-phosphate for breast cancer","volume":"1","author":"Takabe","year":"2012","journal-title":"Gland Surgery"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1405","first-page":"437","article-title":"Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer","volume":"15","author":"Takanami","year":"2006","journal-title":"Oncology Reports"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1410","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/bbrc.2000.3140","article-title":"The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor","volume":"274","author":"Takasaki","year":"2000","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1415","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fimmu.2020.00324","article-title":"Prostaglandin E receptor 4 antagonist in cancer immunotherapy: Mechanisms of action","volume":"11","author":"Take","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1420","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1084\/jem.20102392","article-title":"DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling","volume":"208","author":"Tal","year":"2011","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1425","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","article-title":"Lymphangiogenesis: Molecular mechanisms and future promise","volume":"140","author":"Tammela","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1430","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ncb2331","article-title":"VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling","volume":"13","author":"Tammela","year":"2011","journal-title":"Nature Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1435","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0929-7855(95)00031-K","article-title":"Prostacyclin and thromboxane synthases","volume":"12","author":"Tanabe","year":"1995","journal-title":"Journal of Lipid Mediators and Cell Signalling"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1440","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.coi.2018.04.028","article-title":"Lymphatics in the liver","volume":"53","author":"Tanaka","year":"2018","journal-title":"Current Opinion in Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1445","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/84117","article-title":"Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation","volume":"8","author":"Thunnissen","year":"2001","journal-title":"Nature Structural Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1450","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3920","article-title":"Leukotriene B4 antagonism ameliorates experimental lymphedema","volume":"9","author":"Tian","year":"2017","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1455","doi-asserted-by":"crossref","first-page":"21360","DOI":"10.1016\/S0021-9258(19)36618-9","article-title":"Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells","volume":"267","author":"Tigyi","year":"1992","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1460","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0163-7827(03)00035-3","article-title":"Molecular mechanisms of lysophosphatidic acid action","volume":"42","author":"Tigyi","year":"2003","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1465","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1189\/jlb.1105653","article-title":"Tumor and lymph node lymphangiogenesis--impact on cancer metastasis","volume":"80","author":"Tobler","year":"2006","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1470","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0163-7827(95)00001-G","article-title":"A family of phospholipid autacoids: Occurrence, metabolism and bioactions","volume":"34","author":"Tokumura","year":"1995","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1475","doi-asserted-by":"crossref","first-page":"39436","DOI":"10.1074\/jbc.M205623200","article-title":"Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase","volume":"277","author":"Tokumura","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2016.12.031","article-title":"Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2\/PGE2\/STAT3 axis","volume":"389","author":"Tong","year":"2017","journal-title":"Cancer Letters"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1485","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2012-11-468264","article-title":"Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells","volume":"122","author":"Trinath","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1490","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/aja.1001800209","article-title":"Light and electron microscope observations of the lymphatic drainage units of the peritoneal cavity of rodents","volume":"180","author":"Tsilibary","year":"1987","journal-title":"The American Journal of Anatomy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1495","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biopha.2009.04.034","article-title":"Recruited bone marrow cells expressing the EP3 prostaglandin E receptor subtype enhance angiogenesis during chronic inflammation","volume":"64","author":"Ueno","year":"2010","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1500","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood-2009-04-216069","article-title":"Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation","volume":"115","author":"Uhrin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1505","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.200204026","article-title":"Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production","volume":"158","author":"Umezu-Goto","year":"2002","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1510","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/37622","article-title":"Role of cytosolic phospholipase A2 in allergic response and parturition","volume":"390","author":"Uozumi","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1515","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0929-7855(95)00022-I","article-title":"Molecular biology of prostanoid receptors; an overview","volume":"12","author":"Ushikubi","year":"1995","journal-title":"Journal of Lipid Mediators and Cell Signalling"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1520","doi-asserted-by":"crossref","first-page":"16496","DOI":"10.1016\/S0021-9258(19)84733-6","article-title":"Purification of the thromboxane A2\/prostaglandin H2 receptor from human blood platelets","volume":"264","author":"Ushikubi","year":"1989","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1525","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1101\/gad.303776.117","article-title":"Lymphangiogenesis guidance by paracrine and pericellular factors","volume":"31","author":"Vaahtomeri","year":"2017","journal-title":"Genes & Development"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1530","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/TP.0b013e3181c1afa7","article-title":"Restorative and rejection-associated lymphangiogenesis after renal transplantation: Friend or foe?","volume":"88","author":"Vass","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1535","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/BJ20060251","article-title":"Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient","volume":"397","author":"Venkataraman","year":"2006","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1540","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: Pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nature Reviews. Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1545","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2006.02.023","article-title":"Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages","volume":"9","author":"Visentin","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1550","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1555","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/PPO.0000000000000003","article-title":"An inflammatory mediator, prostaglandin E2, in colorectal cancer","volume":"19","author":"Wang","year":"2013","journal-title":"Cancer Journal"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1560","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4161\/cc.3.12.1288","article-title":"WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth","volume":"3","author":"Wang","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1565","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.sap.0000257149.42922.7e","article-title":"Lymphedema: A comprehensive review","volume":"59","author":"Warren","year":"2007","journal-title":"Annals of Plastic Surgery"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1570","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1084\/jem.20160392","article-title":"S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3\/IL-1\u03b2","volume":"214","author":"Weichand","year":"2017","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1575","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0092-8674(00)81511-1","article-title":"Prox1 function is required for the development of the murine lymphatic system","volume":"98","author":"Wigle","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1580","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI9621","article-title":"Host cyclooxygenase-2 modulates carcinoma growth","volume":"105","author":"Williams","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1585","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0065-2776(04)86007-3","article-title":"Regulation of antigen presentation and cross-presentation in the dendritic cell network: Facts, hypothesis, and immunological implications","volume":"86","author":"Wilson","year":"2005","journal-title":"Advances in Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1590","doi-asserted-by":"crossref","first-page":"27351","DOI":"10.1074\/jbc.274.39.27351","article-title":"Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218\/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins","volume":"274","author":"Windh","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1595","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.4049\/jimmunol.175.8.5152","article-title":"Functional characterization of human cysteinyl leukotriene 1 receptor gene structure","volume":"175","author":"Woszczek","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1600","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1388-1981(02)00181-6","article-title":"Lysophosphatidic acid as an autocrine and paracrine mediator","volume":"1582","author":"Xie","year":"2002","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1605","first-page":"1223","article-title":"Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients","volume":"1","author":"Xu","year":"1995","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1610","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1083\/jcb.200903137","article-title":"Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3","volume":"188","author":"Xu","year":"2010","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1615","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/42506","article-title":"A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis","volume":"387","author":"Yokomizo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1620","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1084\/jem.192.3.421","article-title":"A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders","volume":"192","author":"Yokomizo","year":"2000","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1625","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/01.LAB.0000090159.53224.B9","article-title":"COX-2\/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo","volume":"83","author":"Yoshida","year":"2003","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1630","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","article-title":"Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling","volume":"150","author":"Yu","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1635","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.immuni.2008.12.022","article-title":"Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response","volume":"30","author":"Zhang","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1640","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1182\/blood-2010-11-317800","article-title":"Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor","volume":"118","author":"Zheng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2021.108011_bb1645","doi-asserted-by":"crossref","first-page":"a006494","DOI":"10.1101\/cshperspect.a006494","article-title":"Myeloid cells and lymphangiogenesis","volume":"2","author":"Zumsteg","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:19:21Z","timestamp":1759011561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":327,"alternative-id":["S0163725821002138"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108011","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologically active lipids in the regulation of lymphangiogenesis in disease states","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108011"}}